Clinical Trials Directory

Trials / Completed

CompletedNCT02334059

Effect of Single Dose Ketamine and Magnesium on Postoperative Pain in Patients Undergoing Bariatric Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
108 (actual)
Sponsor
Milton S. Hershey Medical Center · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Opioid sparing analgesia is extremely important in the post-operative obese population. With more and more obese patients entering the operating room a multi-modal approach to analgesia is crucial. Finding effective alternatives to opioid therapy is the rationale of this proposal. Literature involving ketamine and magnesium in bariatric surgical patients is very sparse.

Detailed description

1. Patient will be identified by surgeon and consented by member of the research team 2. Patient will be randomized to one of three groups on the day of surgery 3. Following securement of the endotracheal tube, the study medication will be administered over 10 minutes via an IV infusion pump. 4. The subject will receive ketamine, ketamine plus magnesium or a placebo. 5. Following surgery, the patient will be taken to the post anesthesia care unit (PACU) and set up with standard ASA monitoring as well as end-tidal CO2 via nasal cannula. A hydromorphone patient controlled analgesia (PCA) pump will be set-up by nursing and given to the patient. Standard dosing of 0.2 mg bolus, every 6 minutes with a maximum 2 mg will be the starting dose as is standard for these patients post-operatively. 6. Primary outcome will be the total amount of hydromorphone used in the first 24 hours post-operatively. .

Conditions

Interventions

TypeNameDescription
DRUGKetamineKetamine infusion plus placebo infusion of normal saline
DRUGKetamine plus magnesiumKetamine plus magnesium infusion
OTHERPlacebo2 placebo infusions

Timeline

Start date
2015-11-01
Primary completion
2019-03-13
Completion
2019-03-13
First posted
2015-01-08
Last updated
2020-06-01
Results posted
2019-11-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02334059. Inclusion in this directory is not an endorsement.